Literature DB >> 33715443

The use of whole blood capillary samples to measure 15 analytes for a home-collect biochemistry service during the SARS-CoV-2 pandemic: A proposed model from North West London Pathology.

Saleem Ansari1, Mariana Abdel-Malek1, Julia Kenkre1,2, Sirazum M Choudhury1,2, Sophie Barnes1, Shivani Misra1,2, Tricia Tan1,2, Jaimini Cegla1,2.   

Abstract

BACKGROUND: The COVID-19 pandemic has drastically changed the delivery of secondary care services. Self-collection of capillary blood at home can facilitate the monitoring of patients with chronic disease to support virtual clinics while mitigating the risk of SARS-CoV-2 infection and transmission.
OBJECTIVE: To investigate the comparability of whole blood capillary and plasma venous samples for 15 routinely used biochemical analytes and to develop and pilot a user-friendly home-collection kit to support virtual outpatient clinical services.
METHODS: To investigate the comparability of whole blood capillary and plasma venous samples for 15 routinely requested biochemical analytes, simultaneous samples of venous and capillary blood were collected in EDTA and lithium-heparin plasma separation tubes that were of 4-6 mL and 400-600 µL draw volume, respectively. Venous samples were analysed within 4 h of collection while capillary samples were kept at ambient temperature for three days until centrifugation and analysis. Analyte results that were comparable between the matrices were then piloted in a feasibility study in three outpatient clinical services.
RESULTS: HbA1c, lipid profile and liver function tests were considered comparable and piloted in the patient feasibility study. The home-collect kit demonstrated good patient usability.
CONCLUSION: Home collection of capillary blood could be a clinically-useful tool to deliver virtual care to patients with chronic disease.

Entities:  

Keywords:  Laboratory methods; evaluation of new methods; laboratory management

Year:  2021        PMID: 33715443     DOI: 10.1177/00045632211004995

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  1 in total

1.  Remote capillary blood collection for HbA1c measurement during the COVID-19 pandemic: A laboratory and patient perspective.

Authors:  Wendy N Groenendijk; Tomás P Griffin; Md N Islam; Liam Blake; Deirdre Wall; Marcia Bell; Paula M O'Shea
Journal:  Diabet Med       Date:  2022-06-19       Impact factor: 4.213

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.